Evicenter
MarkdownMedical informationP&T meetings
Barzolvolimab (CDX-0159)

Chronic spontaneous urticaria

Launch
Not announced
Last updated
177 sources

Product information and disease descriptionPlace of product in therapyDisease description

Pathophysiology

13 evidence topics · 13 sources

Mast cell activation as the central mechanism
Other cells, receptors, and pathways: T cells, B cells, eosinophils, basophils, MRGPRX2, complement, and coagulation
Biomarkers of type IIb autoimmune CSU: low total IgE, elevated IgG-anti-TPO, basopenia, eosinopenia, and basophil tests
KIT and stem cell factor: mast cell dependence on SCF/KIT signaling for survival and maturation
Mast cell depletion through KIT as a therapeutic mechanism